Table 1.
Results with PTT as a primary treatment
| Author/year | No of patients | Study design | Disease phase | Device | Daily use (hours) | Treatment duration (months) | Mean SPL before (cm) | Gain in SPL (cm) | Mean curvature | Change in curvature |
|---|---|---|---|---|---|---|---|---|---|---|
| Levine/200818 | 10 | Cohort | Mixed | FastSize Penile Extender | 2-8 | 6 | 10.65 | 0.95 | 51° (30-85) | 22°/33% |
| Gontero/200917 | 19 | Cohort | Mixed | Andropenis | 2-8 | 6 | 10.66 | 0.83 | 31° (±1.55) | 4°/13% |
| Martínez-Salamanca/201415 | 55 | NRCT | Acute | Andropeyronie | 6-9 | 6 | 12.4 | 1.5 | 33° (10-90) | 13°/20% |
| Moncada/201916 | 93 | RCT | Chronic | Penimaster PRO | 3-8 | 3 | 11.9 | 1.8 | 72.3° (61-105) | 31°/41% |
| Ziegelmann/201910 | 90 | RCT | Mixed | RestoreX | 0.5-1.5 | 3 | 11.4 | 1.3 | 45.4° (±13.4) | 9°/18% |
PTT = penile traction therapy; NRCT = non-randomized controlled trial; RCT = randomized controlled trial; SPL = stretched penile length.